Poly Medicure Limited

Informe acción NSEI:POLYMED

Capitalización de mercado: ₹175.3b

Poly Medicure Crecimiento futuro

Future controles de criterios 5/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Poly Medicure de 24.6% y 20.2% por año respectivamente. Se prevé que el BPA crezca en un 24.6% al año. Se espera que la rentabilidad financiera sea de 21% en 3 años.

Información clave

22.6%

Tasa de crecimiento de los beneficios

22.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment21.1%
Tasa de crecimiento de los ingresos18.8%
Rentabilidad financiera futura20.3%
Cobertura de analistas

Low

Última actualización26 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

May 12
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 16
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Nov 14
Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Oct 24
Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Sep 08
Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Aug 12
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Jul 13
Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Jun 16
Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

Mar 02
Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Feb 14
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

Oct 16
Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Sep 28
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Sep 08
Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Jun 25
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Jun 07
A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

May 23
Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Feb 23
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Feb 04
There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 12
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Oct 14
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Jul 07
Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Jun 18
Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

May 31
Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

May 26
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

Mar 01
Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

Feb 16
I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Feb 01
How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Jan 17
Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 09
Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Nov 24
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Nov 09
Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Oct 26
Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Oct 06
Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Sep 17
Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Sep 02
Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Previsiones de crecimiento de beneficios e ingresos

NSEI:POLYMED - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
3/31/202724,8375,2843,5545,0541
3/31/202620,7254,2742,2393,9835
3/31/202516,9503,3309863,2194
3/31/202413,7582,583-1092,661N/A
12/31/202313,0462,487N/AN/AN/A
9/30/202312,4982,337-1972,390N/A
6/30/202311,8722,150N/AN/AN/A
3/31/202311,1521,793-4841,908N/A
12/31/202210,6591,566N/AN/AN/A
9/30/202210,1131,411-5331,568N/A
6/30/20229,6001,359N/AN/AN/A
3/31/20229,2311,465-3211,235N/A
12/31/20218,7851,492N/AN/AN/A
9/30/20218,5181,500-228777N/A
6/30/20218,2801,468N/AN/AN/A
3/31/20217,8651,3592361,187N/A
12/31/20207,4481,197N/AN/AN/A
9/30/20207,2181,0943471,543N/A
6/30/20206,9601,028N/AN/AN/A
3/31/20206,8729592231,283N/A
12/31/20196,881947N/AN/AN/A
9/30/20196,6258586031,197N/A
6/30/20196,388719N/AN/AN/A
3/31/20196,1086542851,065N/A
3/31/20185,204706-75750N/A
3/31/20174,550551N/A561N/A
3/31/20164,123483N/A632N/A
3/31/20153,903623N/A633N/A
3/31/20143,222451N/A661N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (24.6% al año) de POLYMED es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (24.6% al año) de POLYMED crezcan más rápidamente que el mercado Indian (17.8% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de POLYMED crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (20.2% al año) de POLYMED crezcan más rápidamente que los del mercado Indian (10.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 17.2% al año) de POLYMED crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de POLYMED sea alta dentro de 3 años (21%)


Descubre empresas en crecimiento